Sawai Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sawai Pharmaceutical Co., Ltd. with three other
companies in this sector in Japan:
KYORIN Holdings, Incorporation
sales of 115.37 billion Japanese Yen [US$1.09 billion]
of which 95%
was Pharmaceutical Business),
Kobayashi Pharmaceutical Co Ltd
(156.76 billion Japanese Yen [US$1.48 billion]
Tsumura & Co
(114.95 billion Japanese Yen [US$1.08 billion]
of which 100%
was Pharmaceutical Items).
Sawai Pharmaceutical Co., Ltd. reported sales of ¥132.43 billion (US$1.25 billion)
March of 2017.
increase of 7.2%
versus 2016, when the company's sales were ¥123.49 billion.
Sales at Sawai Pharmaceutical Co., Ltd. have increased during each of the previous five years
(and since 2012, sales have increased a total of 96%).